Finally, to maintain the effectiveness of this compound, the authors combined ACA-28 with a specific inhibitor of Nrf2 (ML385), demonstrating the efficacy of this combination in inhibiting melanoma cancer cell viability [150]. Here, NFE2L2 is linked to cancer.